{"nct_id":"NCT04475939","title":"Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2020-10-26","start_date_type":"ACTUAL","primary_completion_date":"2025-02-26","primary_completion_date_type":"ACTUAL","completion_date":"2026-02-06","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GSK"]}